| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269563 | HPB | 2012 | 7 Pages |
Abstract
CTâHDRBT represents a safe treatment option for patients with recurrent bile duct cancer. As a part of a multimodal concept, CTâHDRBT might lead to a prolongation of survival in selected patients but further studies are urgently needed to prove this concept.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Carsten Kamphues, Daniel Seehofer, Federico Collettini, Marcus Bahra, Peter Neuhaus, Peter Wust, Timm Denecke, Bernhard Gebauer, Dirk Schnapauff,